Katrina J. Church - Jul 3, 2023 Form 4 Insider Report for Bioventus Inc. (BVS)

Signature
/s/Anthony D'Adamio, Attorney-in-Fact
Stock symbol
BVS
Transactions as of
Jul 3, 2023
Transactions value $
-$1,115
Form type
4
Date filed
7/5/2023, 05:11 PM
Previous filing
Jun 22, 2023
Next filing
Mar 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BVS Class A Common Stock Sale -$1.12K -394 -3.22% $2.83 11.8K Jul 3, 2023 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects shares sold to cover taxes in connection with shares purchased under the Company's 2021 Employee Stock Purchase Plan and a Rule 10b5-1 instruction in place at the time of such purchase.
F2 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $2.829 to $2.83, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F3 Includes 2,000 shares of Class A common stock purchased under the Company's 2021 Employee Stock Purchase Plan since the date of the Reporting Person's last Form 4.